Unitedhealth

Here's a conveniently timed Trump trade

$Unitedhealth(UNH.US)UnitedHealth closed at $401.67, down 13% from its July high of $461.62 but up 58% from its May 2025 crash low. Q2 2026 EPS surged 61.5% YoY to $6.04 with FCF nearly doubling, though revenue growth flattened near zero. Multiple daily oscillators flash oversold with Bollinger lower-band support at $396 being tested. Forward PE sits at 25.4x, near its 5-year median, while dividend yield has climbed to a 5-year high of 2.24%.

Here is every top $SPY performer (RP>85) currently sitting near the 50 day SMA 👀

$Unitedhealth(UNH.US)UnitedHealth (UNH) is showing a solid recovery in my portfolio, currently sitting at +18.44% with the market price around $407.08 versus my average cost of $343.33. I’m still holding with a longer-term view, as I believe the recent weakness created an attractive entry point. The recovery has been encouraging, but I’m staying patient and watching the company’s fundamentals and future growth closely. #TradeShowcase

$Unitedhealth(UNH.US)Holding UnitedHealth through the volatility is finally paying off. My position is now sitting at +20.38%, and this is a great reminder that patience often rewards investors who stick to their conviction instead of reacting to every short-term headline. 📈

I’m not rushing to celebrate or lock in profits just yet. I’ll continue monitoring earnings, business fundamentals, and the overall healthcare sector before making my next move. Every successful investment reinforces the importance of having a plan, managing risk, and letting time work in your favor. Wishing everyone green portfolios and disciplined investing! 💪📊🚀

$Unitedhealth(UNH.US)UNH closed at $419.08 on Friday, sitting right on the 30-day MA (~$419) after pulling back from the $434 Bollinger upper band. A few things I’m watching closely:

Technicals are flashing caution, but also potential support. KDJ is deeply oversold (K at 24, J at 9), ARBR shows an extremely oversold BR reading, and the PSY indicator just broke below its moving average — short-term selling pressure is real. However, MACD remains above the zero line, meaning the broader uptrend hasn’t fully reversed yet.

The setup matters. Price is now testing the 30-day MA as support. If this level holds, it could be a solid re-entry zone for those who missed the prior leg up. A break below $415 (Bollinger lower band) would change the picture.

$Unitedhealth(UNH.US) | BofA Securities reiterates 𝐁𝐮𝐲 on 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟓𝟏𝟐

$Unitedhealth(UNH.US)+23.30% on UNH and still holding. This position has been a great reminder that patience often pays off. While market sentiment around UnitedHealth has been volatile, I chose to stay focused on the company’s long-term fundamentals instead of reacting to short-term price swings. Today’s gain is encouraging, but I’m not treating it as the finish line. I’ll continue monitoring earnings, regulatory developments, and business execution while letting the investment thesis play out. Staying disciplined and avoiding emotional decisions has been one of the biggest lessons from this trade. Looking forward to seeing how this position performs over the long run.

$Unitedhealth(UNH.US) | Baird 𝐮𝐩𝐠𝐫𝐚𝐝𝐞𝐬 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩 to 𝐍𝐞𝐮𝐭𝐫𝐚𝐥, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟒𝟓𝟑 from $𝟐𝟖𝟕

$Unitedhealth(UNH.US) | TD Cowen reiterates 𝐇𝐨𝐥𝐝 on 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩, 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 𝐭𝐨 $𝟒𝟑𝟎 𝐟𝐫𝐨𝐦 $𝟑𝟑𝟕

These 3 invested in the same stock, pay attention ✍️

$Unitedhealth(UNH.US) | Wells Fargo 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 on 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩 to $𝟒𝟖𝟓 from $𝟑𝟗𝟕, maintains 𝐎𝐯𝐞𝐫𝐰𝐞𝐢𝐠𝐡𝐭

$Unitedhealth(UNH.US)Sticking with $Unitedhealth(UNH.US) continues to reward patience. My position is now up 23.30%, and it reminds me that quality companies can recover when market sentiment improves. I accumulated when fear was high instead of chasing momentum, and now the thesis is playing out. I’m still monitoring regulatory developments and earnings closely, but for now I’m happy to let my winners run while managing risk. Investing isn’t about timing every move perfectly—it’s about having conviction when your research supports the opportunity. 📈💪

$Unitedhealth(UNH.US)Added more patience than panic to this UnitedHealth (UNH) position, and it’s paying off with a 20.38% gain so far. Healthcare has faced plenty of uncertainty, but I believed the market was pricing in too much fear. I stayed focused on the company’s long-term fundamentals instead of reacting to short-term headlines. This trade reminds me that the best returns often come from disciplined investing, proper risk management, and letting time do the heavy lifting. Still holding and monitoring the next move carefully. 📈💪

$Unitedhealth(UNH.US) | Bernstein SocGen Group reiterates 𝐎𝐮𝐭𝐩𝐞𝐫𝐟𝐨𝐫𝐦 on 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡, maintains 𝐏𝐓 𝐚𝐭 $𝟒𝟗𝟐

$Unitedhealth(UNH.US)Happy to see my UnitedHealth ($Unitedhealth(UNH.US)) position showing a +16.34% gain today. This investment has been a great reminder that the market often tests our patience before rewarding conviction. There were plenty of negative headlines and uncertainty surrounding the company, but I chose to focus on the long-term fundamentals rather than react emotionally to short-term volatility.

Investing is not about timing every market movement perfectly. It is about identifying quality businesses, managing risk, and giving your investments enough time to work. The recovery in this position reinforces my belief that patience and discipline remain some of the most valuable assets an investor can have.

Still holding and looking forward to what the future brings. One step at a time, one investment at a time. 🚀💪

$Unitedhealth(UNH.US)Started building my position in $Unitedhealth(UNH.US) when market sentiment was extremely negative and uncertainty was everywhere. Instead of reacting to the noise, I focused on the company’s fundamentals and long-term value.

Today, my position is up 17.30%, a reminder that some of the best opportunities often appear when fear is at its highest. Investing isn’t about timing every move perfectly—it’s about having conviction, managing risk, and staying disciplined when others are emotional.

Still holding and letting the thesis play out. One trade doesn’t define the journey, but consistency and patience can make a huge difference over time.

$Unitedhealth(UNH.US)Patience is finally paying off with my $Unitedhealth(UNH.US) position. After all the volatility and negative sentiment surrounding the stock, I stayed focused on the long-term fundamentals instead of reacting to short-term noise.

Currently sitting at +15.38% unrealized gain, with a market value of $402.66 against an average cost of $346.67. The recent recovery has been encouraging, but my investment thesis remains the same — quality companies often go through difficult periods before the market recognizes their value again.

This is a good reminder that investing isn’t about timing every move perfectly. Sometimes it’s simply about having the conviction to hold through uncertainty.

$Unitedhealth(UNH.US) | Mizuho 𝐫𝐚𝐢𝐬𝐞𝐬 𝐏𝐓 on 𝐔𝐧𝐢𝐭𝐞𝐝𝐇𝐞𝐚𝐥𝐭𝐡 𝐆𝐫𝐨𝐮𝐩 to $𝟒𝟔𝟎 from $𝟒𝟒𝟎, maintains 𝐎𝐮𝐭𝐩𝐞𝐫𝐟𝐨𝐫𝐦